Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CLABI1B:LX
451.95
USD
0.27
0.06%
As of 12:59 AM EDT 5/23/2017
Fund Type
SICAV
52Wk Range
355.76 - 467.75
1 Yr Return
10.21%
YTD Return
14.29%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
452.22
52Wk Range
355.76 - 467.75
1 Yr Return
13.80%
YTD Return
14.29%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 05/23/2017)
451.95
Total Assets (m USD) (on 05/23/2017)
158.761
Inception Date
10/05/2001
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
THOMAS AMREIN
Front Load Fee
3.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.17%

Top Fund Holdings

Name Position Value % of Fund
117.28 k 14.59 m 9.01
168.00 k 11.41 m 7.04
70.00 k 9.36 m 5.78
24.00 k 9.30 m 5.74
54.00 k 8.86 m 5.47
70.00 k 7.65 m 4.72
52.00 k 6.30 m 3.89
22.00 k 6.02 m 3.71
65.44 k 5.74 m 3.55
30.00 k 5.12 m 3.16
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-